233 related articles for article (PubMed ID: 10572087)
1. A novel BTB/POZ transcriptional repressor protein interacts with the Fanconi anemia group C protein and PLZF.
Hoatlin ME; Zhi Y; Ball H; Silvey K; Melnick A; Stone S; Arai S; Hawe N; Owen G; Zelent A; Licht JD
Blood; 1999 Dec; 94(11):3737-47. PubMed ID: 10572087
[TBL] [Abstract][Full Text] [Related]
2. Critical residues within the BTB domain of PLZF and Bcl-6 modulate interaction with corepressors.
Melnick A; Carlile G; Ahmad KF; Kiang CL; Corcoran C; Bardwell V; Prive GG; Licht JD
Mol Cell Biol; 2002 Mar; 22(6):1804-18. PubMed ID: 11865059
[TBL] [Abstract][Full Text] [Related]
3. Identification of FAZF as a novel BMP2-induced transcription factor during osteoblastic differentiation.
Ikeda R; Yoshida K; Inoue I
J Cell Biochem; 2007 May; 101(1):147-54. PubMed ID: 17171645
[TBL] [Abstract][Full Text] [Related]
4. Fanconi anemia proteins FANCA, FANCC, and FANCG/XRCC9 interact in a functional nuclear complex.
Garcia-Higuera I; Kuang Y; Näf D; Wasik J; D'Andrea AD
Mol Cell Biol; 1999 Jul; 19(7):4866-73. PubMed ID: 10373536
[TBL] [Abstract][Full Text] [Related]
5. The Fanconi anemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG.
de Winter JP; van der Weel L; de Groot J; Stone S; Waisfisz Q; Arwert F; Scheper RJ; Kruyt FA; Hoatlin ME; Joenje H
Hum Mol Genet; 2000 Nov; 9(18):2665-74. PubMed ID: 11063725
[TBL] [Abstract][Full Text] [Related]
6. Yeast two-hybrid screens imply involvement of Fanconi anemia proteins in transcription regulation, cell signaling, oxidative metabolism, and cellular transport.
Reuter TY; Medhurst AL; Waisfisz Q; Zhi Y; Herterich S; Hoehn H; Gross HJ; Joenje H; Hoatlin ME; Mathew CG; Huber PA
Exp Cell Res; 2003 Oct; 289(2):211-21. PubMed ID: 14499622
[TBL] [Abstract][Full Text] [Related]
7. Fanconi anemia protein complex: mapping protein interactions in the yeast 2- and 3-hybrid systems.
Gordon SM; Buchwald M
Blood; 2003 Jul; 102(1):136-41. PubMed ID: 12649160
[TBL] [Abstract][Full Text] [Related]
8. The Fanconi anemia complementation group C gene product: structural evidence of multifunctionality.
Pang Q; Christianson TA; Keeble W; Diaz J; Faulkner GR; Reifsteck C; Olson S; Bagby GC
Blood; 2001 Sep; 98(5):1392-401. PubMed ID: 11520787
[TBL] [Abstract][Full Text] [Related]
9. Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1.
Hussain S; Witt E; Huber PA; Medhurst AL; Ashworth A; Mathew CG
Hum Mol Genet; 2003 Oct; 12(19):2503-10. PubMed ID: 12915460
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneous activation of the Fanconi anemia pathway by patient-derived FANCA mutants.
Adachi D; Oda T; Yagasaki H; Nakasato K; Taniguchi T; D'Andrea AD; Asano S; Yamashita T
Hum Mol Genet; 2002 Dec; 11(25):3125-34. PubMed ID: 12444097
[TBL] [Abstract][Full Text] [Related]
11. Strong FANCA/FANCG but weak FANCA/FANCC interaction in the yeast 2-hybrid system.
Reuter T; Herterich S; Bernhard O; Hoehn H; Gross HJ
Blood; 2000 Jan; 95(2):719-20. PubMed ID: 10627486
[TBL] [Abstract][Full Text] [Related]
12. In-depth mutational analysis of the promyelocytic leukemia zinc finger BTB/POZ domain reveals motifs and residues required for biological and transcriptional functions.
Melnick A; Ahmad KF; Arai S; Polinger A; Ball H; Borden KL; Carlile GW; Prive GG; Licht JD
Mol Cell Biol; 2000 Sep; 20(17):6550-67. PubMed ID: 10938130
[TBL] [Abstract][Full Text] [Related]
13. A patient-derived mutant form of the Fanconi anemia protein, FANCA, is defective in nuclear accumulation.
Kupfer G; Naf D; Garcia-Higuera I; Wasik J; Cheng A; Yamashita T; Tipping A; Morgan N; Mathew CG; D'Andrea AD
Exp Hematol; 1999 Apr; 27(4):587-93. PubMed ID: 10210316
[TBL] [Abstract][Full Text] [Related]
14. Fanconi anemia group A and C double-mutant mice: functional evidence for a multi-protein Fanconi anemia complex.
Noll M; Battaile KP; Bateman R; Lax TP; Rathbun K; Reifsteck C; Bagby G; Finegold M; Olson S; Grompe M
Exp Hematol; 2002 Jul; 30(7):679-88. PubMed ID: 12135664
[TBL] [Abstract][Full Text] [Related]
15. Investigation of Fanconi anemia protein interactions by yeast two-hybrid analysis.
Huber PA; Medhurst AL; Youssoufian H; Mathew CG
Biochem Biophys Res Commun; 2000 Feb; 268(1):73-7. PubMed ID: 10652215
[TBL] [Abstract][Full Text] [Related]
16. Reduced retinoic acid-sensitivities of nuclear receptor corepressor binding to PML- and PLZF-RARalpha underlie molecular pathogenesis and treatment of acute promyelocytic leukemia.
Guidez F; Ivins S; Zhu J; Söderström M; Waxman S; Zelent A
Blood; 1998 Apr; 91(8):2634-42. PubMed ID: 9531570
[TBL] [Abstract][Full Text] [Related]
17. Interactions of GATA-2 with the promyelocytic leukemia zinc finger (PLZF) protein, its homologue FAZF, and the t(11;17)-generated PLZF-retinoic acid receptor alpha oncoprotein.
Tsuzuki S; Enver T
Blood; 2002 May; 99(9):3404-10. PubMed ID: 11964310
[TBL] [Abstract][Full Text] [Related]
18. Posttranscriptional cell cycle-dependent regulation of human FANCC expression.
Heinrich MC; Silvey KV; Stone S; Zigler AJ; Griffith DJ; Montalto M; Chai L; Zhi Y; Hoatlin ME
Blood; 2000 Jun; 95(12):3970-7. PubMed ID: 10845936
[TBL] [Abstract][Full Text] [Related]
19. Fanconi anemia proteins localize to chromatin and the nuclear matrix in a DNA damage- and cell cycle-regulated manner.
Qiao F; Moss A; Kupfer GM
J Biol Chem; 2001 Jun; 276(26):23391-6. PubMed ID: 11297559
[TBL] [Abstract][Full Text] [Related]
20. Recruitment of SMRT/N-CoR-mSin3A-HDAC-repressing complexes is not a general mechanism for BTB/POZ transcriptional repressors: the case of HIC-1 and gammaFBP-B.
Deltour S; Guerardel C; Leprince D
Proc Natl Acad Sci U S A; 1999 Dec; 96(26):14831-6. PubMed ID: 10611298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]